Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders

Guest User

by: Ryan Underwood
Research News @ Vanderbilt

Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer's patients

Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal